The “all breast tumor samples” univariate analysis of the KMP cohort did not validate what was observed in the CLB cohort, but this discrepancy might reflect the difference in proportion of the ER-positive and ER-negative subclasses in the two cohorts. This evidence concerns the gene ESR1 and breast neoplasm.